South African company, Umuthi Solutions, finds ‘cure’ for coronavirus
As the race intensifies for a globally acceptable Covid-19 vaccine, a South African healthcare firm, Umuthi Solutions says it has found a remedy for the contagion.
The breakthrough was reportedly made over four months ago.
According to a statement on its website, Umuthi, as the medication is called, inactivates the virus thereby completely eliminating the virus using denaturing spike proteins which dose receptor-binding on host cells.
Across the world, researchers are currently testing over 64 vaccines in clinical trials on humans, and 19 have reached the final stages of testing.
At least 85 preclinical vaccines are under active investigation in animals.
Comirnaty, developed by New York-based Pfizer and the German company BioNTech with over 95 per cent, is ranked as the most effective vaccine yet.
However, the developers of Umuthi claims it works within a fraction of a second on moderate to mild cases and within hours to three days on pneumonic cases.
“Umuthi is specific to targets of microbiological significance,” a statement on its website said.
“It goes to the lower and upper respiratory systems on inhalation as a gas or dissolved as an aerosol. It is significant to note that it does not require much energy from the patient for it to work unlike a vaccine would.
“Thus healing is guaranteed as long as Umuthi is applied to the patient –whether it is a mild, moderate or severe case”.
There are currently three remedies produced by the company.
“US01 cures through Inhalation US02 provides nascent oxygen for denaturing the viral protein. US03 disinfects through the aerosol spray,” the company added alongside an R500 (N14,000) price tag for each.
Recall that the World Health Organisation (WHO) had in May welcomed innovations around the world, including repurposing drugs, traditional medicines and developing new therapies in the search for potential treatments.
However, it strongly cautioned against wrongful use of such treatments and the spread of misinformation.
“The use of products to treat Covid-19, which have not been robustly investigated can put people in danger, giving a false sense of security and distracting them from hand-washing and physical distancing which are cardinal in Covid-19 prevention, and may also increase self-medication and the risk to patient safety,” WHO warned.
More than 85 million persons have beeen infected by the coronavirus globally with almost 1.9 million losing their lives.